PT3221331T - Esteroides 6-alquil-7-hidroxi-4-en-3-ona como intermediários para a produção de moduladores de fxr esteroidais - Google Patents

Esteroides 6-alquil-7-hidroxi-4-en-3-ona como intermediários para a produção de moduladores de fxr esteroidais

Info

Publication number
PT3221331T
PT3221331T PT158009092T PT15800909T PT3221331T PT 3221331 T PT3221331 T PT 3221331T PT 158009092 T PT158009092 T PT 158009092T PT 15800909 T PT15800909 T PT 15800909T PT 3221331 T PT3221331 T PT 3221331T
Authority
PT
Portugal
Prior art keywords
steroids
intermediates
hydroxy
alkyl
production
Prior art date
Application number
PT158009092T
Other languages
English (en)
Inventor
Weymouth-Wilson Alexander
Komsta Zofia
Boydell James
Otter Carl
WALLIS Laura
BATCHELOR Rhys
Original Assignee
Nzp Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1420593.4A external-priority patent/GB201420593D0/en
Priority claimed from GBGB1420594.2A external-priority patent/GB201420594D0/en
Priority claimed from GBGB1505670.8A external-priority patent/GB201505670D0/en
Application filed by Nzp Uk Ltd filed Critical Nzp Uk Ltd
Publication of PT3221331T publication Critical patent/PT3221331T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT158009092T 2014-11-19 2015-11-19 Esteroides 6-alquil-7-hidroxi-4-en-3-ona como intermediários para a produção de moduladores de fxr esteroidais PT3221331T (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1420593.4A GB201420593D0 (en) 2014-11-19 2014-11-19 Compounds
GBGB1420594.2A GB201420594D0 (en) 2014-11-19 2014-11-19 Compounds
GBGB1505670.8A GB201505670D0 (en) 2015-04-01 2015-04-01 Compounds

Publications (1)

Publication Number Publication Date
PT3221331T true PT3221331T (pt) 2019-12-23

Family

ID=54704019

Family Applications (1)

Application Number Title Priority Date Filing Date
PT158009092T PT3221331T (pt) 2014-11-19 2015-11-19 Esteroides 6-alquil-7-hidroxi-4-en-3-ona como intermediários para a produção de moduladores de fxr esteroidais

Country Status (16)

Country Link
US (1) US10301350B2 (pt)
EP (1) EP3221331B1 (pt)
JP (1) JP6700274B2 (pt)
KR (1) KR102526631B1 (pt)
CN (1) CN107207559B (pt)
BR (1) BR112017010319B1 (pt)
CA (1) CA2968309A1 (pt)
DK (1) DK3221331T3 (pt)
EA (1) EA033427B1 (pt)
ES (1) ES2759725T3 (pt)
HK (1) HK1246801A1 (pt)
MX (1) MX2017006563A (pt)
PL (1) PL3221331T3 (pt)
PT (1) PT3221331T (pt)
TW (1) TWI690536B (pt)
WO (1) WO2016079517A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2968301C (en) 2014-11-19 2023-05-16 NZP UK Limited 5.beta.-6-alkyl-7-hydroxy-3-one steroids as intermediates for the production of steroidal fxr modulators
TWI686401B (zh) 2014-11-19 2020-03-01 英商Ｎｚｐ英國有限公司 化合物（三）
EA033603B1 (ru) 2014-11-19 2019-11-08 Nzp Uk Ltd 6-альфа-алкил-6,7-дионовые стероиды в качестве промежуточных соединений для получения стероидных модуляторов fxr
CZ2015504A3 (cs) * 2015-07-16 2017-01-25 Zentiva, K.S. Krystalické formy obeticholové kyseliny
BR112018012590A2 (pt) * 2015-12-22 2018-12-04 Intercept Pharmaceuticals Inc formas cristalinas polimórficas do ácido obeticólico
GB201608779D0 (en) * 2016-05-18 2016-06-29 Dextra Lab Ltd Methods and compounds
GB201608776D0 (en) * 2016-05-18 2016-06-29 Dextra Lab Ltd Methods and compounds
GB201608777D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Compounds
EP3548038B1 (en) * 2016-11-29 2022-04-13 Enanta Pharmaceuticals, Inc. Process for preparation of sulfonylurea bile acid derivatives
EP3431486A1 (en) * 2017-07-18 2019-01-23 Bionice, S.L.U. Process and intermediates for the synthesis of obeticholic acid and derivatives thereof
CN111138509B (zh) * 2018-11-02 2022-12-06 东莞东阳光药物研发有限公司 奥贝胆酸的制备方法
CN112521438B (zh) * 2020-12-08 2021-11-23 苏利制药科技江阴有限公司 一种β-谷甾醇的合成工艺
WO2023288123A1 (en) * 2021-07-16 2023-01-19 Interecept Pharmaceuticals, Inc. Methods and intermediates for the preparation of 3.alpha.,7.alpha.,11.beta.-trihydroxy-6.alpha.-ethyl-5.beta.-cholan-24-oic acid
CN113912661B (zh) * 2021-11-11 2023-04-21 湖南科瑞生物制药股份有限公司 一种7-羟基甾体化合物的合成方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2624748A (en) 1950-09-09 1953-01-06 Upjohn Co Bisnorchola-4, 6-dien-3-one-22-al
US4289872A (en) 1979-04-06 1981-09-15 Allied Corporation Macromolecular highly branched homogeneous compound based on lysine units
US5229490A (en) 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
ATE156158T1 (de) 1992-04-14 1997-08-15 Cornell Res Foundation Inc Makromoleküle auf basis von dendritischen polymeren und verfahren zur herstellung
AU6392894A (en) 1993-02-26 1994-09-14 Magainin Pharmaceuticals, Inc. Chemical synthesis of squalamine
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
CA2440680C (en) 2001-03-12 2010-06-01 Roberto Pellicciari Steroids as agonists for fxr
US20090062256A1 (en) 2001-06-01 2009-03-05 Bristol-Myers Squibb Pharma Company LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
MXPA04004336A (es) 2001-11-07 2005-05-16 Nektar Therapeutics Al Corp Polimeros ramificados y sus conjugados.
EP1568706A1 (en) 2004-02-26 2005-08-31 Intercept Pharmaceuticals, Inc. Novel steroid agonist for FXR
ITMI20050912A1 (it) 2005-05-19 2006-11-20 Erregierre Spa Processo di preparazione di acidi 3-a-ya(b)-diidrossi-6-a(b)-alchil-5b-colanici
JP2007210888A (ja) * 2006-01-12 2007-08-23 Mitsubishi Chemicals Corp ステロイド化合物の製造方法
CN101395170A (zh) 2006-02-14 2009-03-25 英特塞普特药品公司 用于预防或治疗fxr介导的疾病或状态的作为fxr配体的胆汁酸衍生物
CN101522703B (zh) 2006-06-27 2013-04-17 英特塞普特医药品公司 胆酸派生物及其在制备预防或治疗fxr介导的疾病或状况的药物中的应用
EA017714B1 (ru) 2007-01-19 2013-02-28 Интерсепт Фармасьютикалз, Инк. Модуляторы tgr5 и способы их применения
BRPI0916735B8 (pt) 2008-07-30 2021-05-25 Intercept Pharmaceuticals Inc compostos moduladores de tgr5, composições farmacêuticas compreendendo os mesmos e seus usos
CN106380502A (zh) 2008-11-19 2017-02-08 英特塞普特医药品公司 G蛋白偶联受体5(tgr5)调节剂及其使用方法
DK2698375T3 (en) 2008-11-19 2018-05-28 Intercept Pharmaceuticals Inc TGR5 modulators and methods for using them
JP2013500986A (ja) 2009-07-29 2013-01-10 ザ・ユニバーシティ・オブ・シカゴ 肝臓ｘ受容体アゴニスト
KR101881245B1 (ko) 2012-06-19 2018-07-23 인터셉트 파마슈티컬즈, 인크. 오베티콜산의 제조법, 용도 및 고체 형태
DK2912013T3 (en) 2012-10-26 2018-01-15 Intercept Pharmaceuticals Inc Process for the preparation of bile acid derivatives
MX2015006710A (es) * 2012-11-28 2016-01-15 Intercept Pharmaceuticals Inc Tratamiento de las enfermedades pulmonares.
US20140206657A1 (en) 2013-01-18 2014-07-24 City Of Hope Bile acid analog tgr5 agonists
CN105377870B (zh) 2013-05-14 2018-04-03 英特塞普特医药品公司 作为法尼醇x受体调节剂的胆汁酸的11‑羟基衍生物及其氨基酸共轭物
EP3004892B1 (en) 2013-05-24 2018-10-10 Nestec S.A. Method for diagnosing irritable bowel syndrome
US10166246B2 (en) 2014-05-27 2019-01-01 City Of Hope TGR5 agonist complexes for treating diabetes and cancer
HUE048351T2 (hu) 2014-05-29 2020-07-28 Bar Pharmaceuticals S R L Kolán-származékok alkalmazása FXR és TGR5/GPBAR1 mediált betegségek kezelésére és/vagy prevenciójára
JP2017533923A (ja) 2014-11-06 2017-11-16 エナンタ ファーマシューティカルズ インコーポレイテッド Ｆｘｒ／ｔｇｒ５アゴニストとしての胆汁酸類似体およびその使用方法
CA2968301C (en) 2014-11-19 2023-05-16 NZP UK Limited 5.beta.-6-alkyl-7-hydroxy-3-one steroids as intermediates for the production of steroidal fxr modulators
EA033603B1 (ru) 2014-11-19 2019-11-08 Nzp Uk Ltd 6-альфа-алкил-6,7-дионовые стероиды в качестве промежуточных соединений для получения стероидных модуляторов fxr
TWI686401B (zh) 2014-11-19 2020-03-01 英商Ｎｚｐ英國有限公司 化合物（三）
WO2016086134A1 (en) 2014-11-26 2016-06-02 Enanta Pharmaceuticals, Inc. Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
US10208081B2 (en) 2014-11-26 2019-02-19 Enanta Pharmaceuticals, Inc. Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
MX2017006833A (es) 2014-11-26 2018-02-13 Enanta Pharm Inc Análogos de ácido biliar como agonistas de fxr/tgr5 y métodos para el uso de los mismos.
WO2016086115A1 (en) 2014-11-26 2016-06-02 Enanta Pharmaceuticals, Inc. Tetrazole derivatives of bile acids as fxr/tgr5 agonists and methods of use thereof
CN106279328A (zh) 2015-05-20 2017-01-04 重庆药友制药有限责任公司 一种制备6α-烷基鹅去氧胆酸的方法
PT3310801T (pt) 2015-06-24 2021-06-18 Intercept Pharmaceuticals Inc Moduladores de tgr5 e métodos de utilização dos mesmos
CN106397522A (zh) 2015-07-31 2017-02-15 中国人民解放军军事医学科学院毒物药物研究所 3,7‑二（叔丁基二甲基硅基氧基）‑6‑烯‑5β‑胆烷‑24‑酸甲酯
CN106478759A (zh) 2015-08-31 2017-03-08 陕西合成药业股份有限公司 奥贝胆酸衍生物及其制备方法和用途
CN106478756A (zh) 2015-09-02 2017-03-08 中美华世通生物医药科技（武汉）有限公司 Oca-e单晶及其制备方法和用途
CN106518946A (zh) 2015-09-10 2017-03-22 上海迪诺医药科技有限公司 磺酰脲衍生物、其药物组合物及应用

Also Published As

Publication number Publication date
TW201632537A (zh) 2016-09-16
CN107207559A (zh) 2017-09-26
TWI690536B (zh) 2020-04-11
JP6700274B2 (ja) 2020-05-27
KR20170086604A (ko) 2017-07-26
ES2759725T3 (es) 2020-05-12
WO2016079517A1 (en) 2016-05-26
CN107207559B (zh) 2019-10-25
EP3221331B1 (en) 2019-09-18
US20170327528A1 (en) 2017-11-16
MX2017006563A (es) 2018-01-26
KR102526631B1 (ko) 2023-04-27
EA201790884A1 (ru) 2017-11-30
EP3221331A1 (en) 2017-09-27
CA2968309A1 (en) 2016-05-26
NZ731924A (en) 2020-12-18
EA201790884A8 (ru) 2019-07-31
BR112017010319A2 (pt) 2017-12-26
US10301350B2 (en) 2019-05-28
EA033427B1 (ru) 2019-10-31
HK1246801A1 (zh) 2018-09-14
JP2017534670A (ja) 2017-11-24
PL3221331T3 (pl) 2020-03-31
BR112017010319B1 (pt) 2023-04-11
DK3221331T3 (da) 2019-12-02

Similar Documents

Publication Publication Date Title
HK1246801A1 (zh) 作為製備類固醇fxr調節劑的中間體的6-烷基-7-羥基-4-烯-3-酮類固醇
HK1245326A1 (zh) 用於生產scaav的組合物和方法
HK1244285B (zh) 作為製備類固醇FXR調節劑的中間體的5β-6-烷基-7-羥基-3-酮類固醇
EP3108075A4 (en) Method of configuring walls
EP3136857A4 (en) Crystalline form of baricitinib
HK1244286A1 (zh) 作為製備類固醇FXR調節劑的中間體的6α-烷基-6，7-二酮類固醇
HK1244287A1 (zh) 作為製備類固醇FXR調節劑的中間體的6α-烷基-3，7-二酮類固醇
EP3230280A4 (en) Process for preparation of luliconazole
EP3164128A4 (en) Amorphous form of eliglustat hemitartarate
IL248267A0 (en) A process for preparing converted cycloserines
EP3237424A4 (en) Process of making cenicriviroc and related analogs
GB201418395D0 (en) Cyclo-depolymerisation of polybutadiene
EP3234764A4 (en) Instrumentation of graphics instructions
IL285700A (en) 21- Hydroxylation of steroids
EP3303364A4 (en) Production of sterols
EP3152691A4 (en) Refining of material definitions for designed parts
IL247234A0 (en) Caspase-6 modulators
IL247443B (en) Process for the preparation of 5-fluorotryptophol
GB2531092B (en) Production of airframe components
EP3201215A4 (en) Methods of preparing intermediate of fluticasone propionate
EP3177461A4 (en) A kit for forming a panel and a method of forming a panel
IL237572A0 (en) Process and intermediates for the preparation of dastinib
HUE055367T2 (hu) Eljárás új intermedierek 11-metilén-szteroidok elõállítására
PT3395819T (pt) Forma cristalina de derivado de aminopirano substituído
PT3102565T (pt) Processos para a preparação de intermediários de raltegravir